NCT02814383

Brief Summary

Extremely low birth weight (ELBW), birth weight less than or equal to 1000 g, infants are at high risk for developing brain injury in the first week of life. Intraventricular hemorrhage (IVH) and periventricular leukomalacia (PVL) are the most common injuries in this group of infants. Their incidence is inversely proportional to gestational age (GA) and birth weight (BW). These lesions are associated with neurodevelopmental delay, poor cognitive performance, visual and hearing impairment, epilepsy, and cerebral palsy; and instability of systemic hemodynamics during transition from intra- to extra-uterine life and during the early neonatal period is believed to be at their genesis. While the incidence of ultrasound- diagnosed cystic PVL has decreased dramatically over the last 2 decades, diffuse PVL detected by magnetic resonance imaging (MRI) is still prevalent in survivors of neonatal intensive care. Moreover, PVL, even when non-cystic, is associated with decreased cortical complexity and brain volume and eventual neurocognitive impairment. Currently, clinicians lack the tools to detect changes in cerebral perfusion prior to irreversible injury. Unfortunately, the incidence of brain injury in ELBW infants has remained relatively stable. Once translated to the bedside, the goal of this research is to develop a monitoring system that will allow researchers to identify infants most at risk for IVH and PVL and in the future, intervention studies will be initiated to use the changes in cerebral perfusion to direct hemodynamic management. The purpose of this study is to first understand the physiology of brain injury and then to eventually impact the outcomes in this high-risk group of infants by assessing the ability of the diastolic closing margin (DCM), a non-invasive estimate of brain perfusion pressure, to predict hemorrhagic and ischemic brain injury in ELBW infants. The information collected for this study will help develop algorithms or monitoring plans that will maintain the appropriate brain perfusion pressure and thereby, prevent severe brain injury.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
310

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Aug 2016

Longer than P75 for all trials

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 26, 2016

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 27, 2016

Completed
2 months until next milestone

Study Start

First participant enrolled

August 11, 2016

Completed
8.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 21, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 21, 2025

Completed
Last Updated

May 23, 2025

Status Verified

May 1, 2025

Enrollment Period

8.8 years

First QC Date

May 26, 2016

Last Update Submit

May 20, 2025

Conditions

Keywords

PrematurityExtremely Low Birth Weight (ELBW)Cerebral PerfusionCerebral Autoregulation

Outcome Measures

Primary Outcomes (1)

  • Brain Perfusion

    Brain perfusion will be assessed by calculating the diastolic closing margin (DCM). DCM will be measured from continuous recordings of middle cerebral artery cerebral blood flow velocity (CBFV) by transcranial Doppler ultrasound and ABP during first week of life for ELBW infants.

    1 Week

Secondary Outcomes (11)

  • Brain Perfusion

    1 Week

  • Brain Perfusion

    1 Week

  • Brain Injury (IVH)

    1 Week

  • Brain Injury (PVL)

    7 Weeks

  • Brain Injury (PVL)

    7 Weeks

  • +6 more secondary outcomes

Study Arms (1)

ELBW Infants

This study seeks to collect data on premature ELBW infants (less than or equal to 2.2 lbs) at high risk of developing brain injury.

Other: Brain Monitoring Platform

Interventions

This study is being done to evaluate the changes in brain perfusion measured by the DCM using a comprehensive and innovative brain monitoring platform that encompasses direct and continuous measures of cerebral blood flow (CBF), cerebral oximetry, cerebral autoregulation, partial pressure of carbon dioxide (PCO2), and arterial blood pressure (ABP).

ELBW Infants

Eligibility Criteria

Age0 Hours - 12 Hours
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Within 12 hours of life, subjects' mothers will be approached for participation in this research study. This study seeks to collect data on premature ELBW infants (less than or equal to 2.2 lbs) at high risk of developing brain injury.

You may qualify if:

  • Informed consent obtained from parent or legally authorized representative (LAR)
  • Live-born ELBW infant
  • Less than 12 hours of life
  • Birth weight 401 to 1000g
  • Admitted to Texas Children's Hospital (TCH) Pavilion for Women (PFW) Neonatal Intensive Care Unit (NICU)
  • Umbilical arterial catheter (UAC) in place

You may not qualify if:

  • Complex congenital anomalies of central nervous system (CNS)
  • Complex chromosomal congenital anomalies
  • Hydrops fetalis
  • Poor skin integrity
  • Live-born but receiving only comfort care
  • Grade 3-4 IVH by head ultrasound (HUS) at the first ultrasound completed at or before 12 hours of life

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Baylor College of Medicine

Houston, Texas, 77030, United States

Location

Texas Children's Hospital

Houston, Texas, 77030, United States

Location

Texas Children's Pavilion for Women

Houston, Texas, 77030, United States

Location

Related Links

MeSH Terms

Conditions

Leukomalacia, PeriventricularBrain InjuriesPremature Birth

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesEncephalomalaciaVascular DiseasesCardiovascular DiseasesInfant, Premature, DiseasesInfant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesCraniocerebral TraumaTrauma, Nervous SystemWounds and InjuriesObstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Christopher J. Rhee, MD

    Baylor College of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

May 26, 2016

First Posted

June 27, 2016

Study Start

August 11, 2016

Primary Completion

May 21, 2025

Study Completion

May 21, 2025

Last Updated

May 23, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations